The Expression of Basal Cytokeratins in Breast Cancers

Dr. Vidhya Lakshmi S; Dr. Seyed Rabia

Authors

Dr. Vidhya Lakshmi S
Dr. Seyed Rabia

Keywords:

triple negative breast cancers, cytokeratin 5/6, basal-like breast carcinoma

Abstract

Abstract not found

Downloads

How to Cite

The Expression of Basal Cytokeratins in Breast Cancers. (2018). Global Journal of Medical Research, 17(C2), 17-21. https://medicalresearchjournal.org/index.php/GJMR/article/view/1412

Download Citation

References

Emad Rakha, Jorge Reis-Filho (2009) Basal-like Breast Carcinoma: From Expression Profiling to Routine Practice. 133(6), 860-868.

M Heatley, P Maxwell, C Whiteside, P Toner (1994) Cytokeratin intermediate filament expression in benign and malignant breast disease.. 48(1), 26-32.

D Barnes, A Hanby (2001) Oestrogen and progesterone receptors in breast cancer: past, present and future. 38(3), 271-274.

G Glass, J V Lacey, J Carreon, R Hoover (2007) Breast cancer incidence 1980-2006: Combined roles of menopausal hormone therapy, screening mammography and Estrogen receptor status. 99(15), 1152-1161.

M Laakso, M Tanner, J Nilsson (2006) Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer. 12, 4185-4191.

David Sarrió, Socorro Rodriguez-Pinilla, David Hardisson, Amparo Cano, Gema Moreno-Bueno, José Palacios (2008) Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype. 68(4), 989-997.

D Doval, A Sharma, R Sinha, K Kumar, A Dewan, H Chaturvedi Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in South India. 12, 625-629.

J Harvey, G Clark, Osbourne Ck, D Allred (1999) Estrogen receptor status by immunohistochemistry is superior to ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. 17(5), 1474-1481.

A Gown (2008) Current issues in ER and HER2 testing by IHC in breast cancer. 21, 8-S15.

Jessica Dolle, Janet Daling, Emily White, Louise Brinton, David Doody, Peggy Porter, Kathleen Malone (2009) Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years. 18(4), 1157-1166.

S Clark, J Warwick, R Carpenter, R Bowen, S Duffy, J Jones (2011) Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. 104(1), 120-127.

O Torsten, Forrest Nielsen, Kristin Hsu, Maggie Jensen, Gamze Cheang, Zhiyuan Karaca, Tina Hu, Hernandez-Boussard (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. 10, 5367-5374.